These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 32406793)
41. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer. Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112 [TBL] [Abstract][Full Text] [Related]
42. The lncRNA MALAT1 functions as a competing endogenous RNA to regulate MCL-1 expression by sponging miR-363-3p in gallbladder cancer. Wang SH; Zhang WJ; Wu XC; Weng MZ; Zhang MD; Cai Q; Zhou D; Wang JD; Quan ZW J Cell Mol Med; 2016 Dec; 20(12):2299-2308. PubMed ID: 27420766 [TBL] [Abstract][Full Text] [Related]
43. miR-365 inhibits the progression of gallbladder carcinoma and predicts the prognosis of Gallbladder carcinoma patients. Jiang ZB; Ma BQ; Feng Z; Liu SG; Gao P; Yan HT Cell Cycle; 2021 Feb; 20(3):308-319. PubMed ID: 33459111 [TBL] [Abstract][Full Text] [Related]
44. Loss of MTUS1 Expression Is Associated With Poor Prognosis in Patients With Gallbladder Carcinoma. Sim J; Kim Y; Kim H; Bang S; Jee S; Park S; Shin SJ; Jang K In Vivo; 2020; 34(1):125-132. PubMed ID: 31882471 [TBL] [Abstract][Full Text] [Related]
45. Differential microRNA expression in the peripheral blood from human patients with COVID-19. Li C; Hu X; Li L; Li JH J Clin Lab Anal; 2020 Oct; 34(10):e23590. PubMed ID: 32960473 [TBL] [Abstract][Full Text] [Related]
46. miR-145 sensitizes gallbladder cancer to cisplatin by regulating multidrug resistance associated protein 1. Zhan M; Zhao X; Wang H; Chen W; Xu S; Wang W; Shen H; Huang S; Wang J Tumour Biol; 2016 Aug; 37(8):10553-62. PubMed ID: 26852750 [TBL] [Abstract][Full Text] [Related]
48. MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer. Jakob M; Mattes LM; Küffer S; Unger K; Hess J; Bertlich M; Haubner F; Ihler F; Canis M; Weiss BG; Kitz J Head Neck; 2019 Oct; 41(10):3499-3515. PubMed ID: 31355988 [TBL] [Abstract][Full Text] [Related]
49. Extracellular vesicle-shuttled miRNAs as a diagnostic and prognostic biomarker and their potential roles in gallbladder cancer patients. Ueta E; Tsutsumi K; Kato H; Matsushita H; Shiraha H; Fujii M; Matsumoto K; Horiguchi S; Okada H Sci Rep; 2021 Jun; 11(1):12298. PubMed ID: 34112884 [TBL] [Abstract][Full Text] [Related]
50. miRNAs orchestration of gallbladder cancer - Particular emphasis on diagnosis, progression and drug resistance. Shahin RK; Elkady MA; Abulsoud AI; Abdelmaksoud NM; Abdel Mageed SS; El-Dakroury WA; Zewail MB; Elazazy M; Sobhy MH; Nomier Y; Elazazy O; Elballal MS; Mohammed OA; Midan HM; Elrebehy MA; Ziada BO; Doghish AS Pathol Res Pract; 2023 Aug; 248():154684. PubMed ID: 37454489 [TBL] [Abstract][Full Text] [Related]
51. Long non-coding RNA MINCR promotes gallbladder cancer progression through stimulating EZH2 expression. Wang SH; Yang Y; Wu XC; Zhang MD; Weng MZ; Zhou D; Wang JD; Quan ZW Cancer Lett; 2016 Sep; 380(1):122-33. PubMed ID: 27345740 [TBL] [Abstract][Full Text] [Related]
52. MiR-335 promotes cell proliferation by inhibiting MEF2D and sensitizes cells to 5-Fu treatment in gallbladder carcinoma. Wang W; Chen LC; Qian JY; Zhang Q Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9829-9839. PubMed ID: 31799650 [TBL] [Abstract][Full Text] [Related]
53. Serum miR-1181 and miR-4314 associated with ovarian cancer: MiRNA microarray data analysis for a pilot study. Ruan L; Xie Y; Liu F; Chen X Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():31-38. PubMed ID: 29353130 [TBL] [Abstract][Full Text] [Related]
54. miR-143-3p targeting of ITGA6 suppresses tumour growth and angiogenesis by downregulating PLGF expression via the PI3K/AKT pathway in gallbladder carcinoma. Jin YP; Hu YP; Wu XS; Wu YS; Ye YY; Li HF; Liu YC; Jiang L; Liu FT; Zhang YJ; Hao YJ; Liu XY; Liu YB Cell Death Dis; 2018 Feb; 9(2):182. PubMed ID: 29416013 [TBL] [Abstract][Full Text] [Related]
55. Increased expression of RBMS3 predicts a favorable prognosis in human gallbladder carcinoma. Wu Y; Meng D; You Y; Sun R; Yan Q; Bao J; Sun Y; Yun D; Li Y; Sun D Oncol Rep; 2020 Jul; 44(1):55-68. PubMed ID: 32627033 [TBL] [Abstract][Full Text] [Related]
56. Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression. Kandhavelu J; Subramanian K; Khan A; Omar A; Ruff P; Penny C Microrna; 2019; 8(1):68-75. PubMed ID: 30073936 [TBL] [Abstract][Full Text] [Related]
57. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients. Zhang C; Zhang CD; Ma MH; Dai DQ World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201 [TBL] [Abstract][Full Text] [Related]
58. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs. He H; Wang L; Zhou W; Zhang Z; Wang L; Xu S; Wang D; Dong J; Tang C; Tang H; Yi X; Ge J PLoS One; 2015; 10(5):e0125672. PubMed ID: 25938468 [TBL] [Abstract][Full Text] [Related]
59. Screening the key microRNAs and transcription factors in prostate cancer based on microRNA functional synergistic relationships. Feng F; Wu J; Gao Z; Yu S; Cui Y Medicine (Baltimore); 2017 Jan; 96(1):e5679. PubMed ID: 28072703 [TBL] [Abstract][Full Text] [Related]